HCWB
HCWB
NASDAQ · Biotechnology

Hcw Biologics Inc

$5.06
-0.20 (-3.73%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +288.9% upside
Low Target $12.72
Average Target $19.68
High Target $25.92
Current Price $5.06
Current
$5.06
Target
$19.68
$12.72 $19.68 avg $25.92
Scenario Analysis
Bear Case
$12.72
151.4%
Low target
Base Case
$19.68
+288.9%
Avg target
Bull Case
$25.92
+412.3%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$7.35
-31.2% from high
52-Week Low
$0.25
+1,924.0% from low
Target vs 52W High
$19.68
+167.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +1.3%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.1%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -12.3%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -65.1%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -40.8%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -47.5%